ONB
AZN icon

Old National Bancorp’s AstraZeneca AZN Stock Holding History

Old National Bancorp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
6,312
+1,116
+21% +$210K 0.02% 273
2026
Q1 		$1.02M Sell
5,196
-933
-15% -$180K 0.02% 308
2025
Q4 		$1.13M Buy
6,129
+40
+0.7% +$7.01K 0.02% 294
2025
Q3 		$934K Buy
6,089
+486
+9% +$73.6K 0.02% 312
2025
Q2 		$783K Sell
5,603
-946
-14% -$133K 0.01% 325
2025
Q1 		$963K Buy
6,549
+45
+0.7% +$6.51K 0.03% 265
2024
Q4 		$852K Buy
6,504
+330
+5% +$46.2K 0.02% 307
2024
Q3 		$962K Buy
6,174
+2,041
+49% +$329K 0.02% 296
2024
Q2 		$645K Sell
4,133
-770
-16% -$116K 0.02% 328
2024
Q1 		$664K Sell
4,903
-829
-14% -$110K 0.02% 335
2023
Q4 		$772K Buy
5,732
+1,057
+23% +$137K 0.02% 326
2023
Q3 		$633K Buy
4,675
+129
+3% +$17.6K 0.02% 347
2023
Q2 		$651K Sell
4,546
-3,195
-41% -$470K 0.02% 359
2023
Q1 		$1.07M Sell
7,741
-489
-6% -$65.8K 0.03% 297
2022
Q4 		$1.12M Buy
8,230
+859
+12% +$108K 0.04% 295
2022
Q3 		$809K Buy
7,371
+1,386
+23% +$176K 0.03% 331
2022
Q2 		$790K Buy
5,985
+3,346
+127% +$439K 0.03% 335
2022
Q1 		$350K Sell
2,639
-6
-0.2% -$720 0.01% 403
2021
Q4 		$308K Buy
2,645
+99
+4% +$11.6K 0.01% 424
2021
Q3 		$306K Hold
2,546
– – 0.01% 422
2021
Q2 		$305K Buy
+2,546
New +$279K 0.01% 428
2017
Q3 		– Sell
-2,938
Closed -$201K – 622
2017
Q2 		$201K Buy
+2,938
New +$192K 0.01% 590
2014
Q2 		– Sell
-4,108
Closed -$267K – 539
2014
Q1 		$267K Sell
4,108
-107
-3% -$6.91K 0.02% 357
2013
Q4 		$250K Sell
4,215
-264
-6% -$14.3K 0.02% 300
2013
Q3 		$233K Buy
4,479
+221
+5% +$11.1K 0.02% 277
2013
Q2 		$201K Buy
+4,258
New +$217K 0.02% 289

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Old National Bancorp's AZN Position: Q2 2026 in Review

Old National Bancorp increased its AstraZeneca (AZN) stake by 21% in Q2 2026, buying an estimated $210K and bringing the position to 6,312 shares worth $1.2M. The position accounts for 0.02% of the portfolio, ranked #273.

Old National Bancorp first reported a position in AZN in Q2 2013 and has held it in 26 quarters since. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Old National Bancorp held 6,312 shares of AstraZeneca worth $1.2M as of Q2 2026.
  • Old National Bancorp bought 1,116 AstraZeneca shares in Q2 2026, an estimated $210K.
  • AstraZeneca made up 0.02% of Old National Bancorp's portfolio in Q2 2026, its #273 holding.
  • Old National Bancorp first reported a position in AstraZeneca in Q2 2013 and has held it in 26 quarters since.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.